Type
1.
Júnior IAR, Chaves AT, de Andrade LC, Lyon S, Grossi MA de F, Brito RM de M, et al. Detection of sensory deficits in fine nerve fibres in leprosy diagnosis. Tropical medicine & international health : TM & IH. 2025;
Type
1.
Nagarajan HDP, Kamaraj B, Selvanathan K, Kukunoor PR, Manichandana K, Manideep K, et al. Bullous Type 2 Lepra Reaction: A Rare and Significant Case Report. Clinical case reports [Internet]. 2025;13(1):1-6. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11702396/pdf/CCR3-13-e70056.pdf
Type
1.
Suresh B, Reshmi PR, Jaipal J, Pise GA, Prasad SS, Manohar N. Tofacitinib in Leprosy: A Novel Therapeutic Approach in Chronic Recalcitrant Type II Reactions. Cureus [Internet]. 2024;16(11):1-5. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11681993/pdf/cureus-0016-00000074694.pdf
Type
1.
de Oliveira ALG, Brito RM de M, Siqueira WF, de Jesus ACP, Bueno LL, Fujiwara RT. IgG seroprevalence of Toxoplasma gondii and Leishmania infantum in leprosy patients: Implications for screening and management of co-infections. Diagnostic microbiology and infectious disease. 2024;110(1).
Type
1.
Mehta S, Bhatia K, Namdeo C. "The Diverse Faces of Hansen’s Disease: A Pictorial Review". Journal of the American Academy of Dermatology. 2024;
Type
1.
Kondo S, Okano Y, Iraha S, Tokunaga S. Substance P- and Insulin-like Growth Factor 1-derived Tetrapeptides for Neurotrophic Keratopathy Related to Leprosy: A Clinical Trial. Ophthalmology science [Internet]. 2024;5(2):1-9. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11665617/pdf/main.pdf
Type
1.
Vidal SL, Lages DDS, Maciel ICL, Leite ICG, Coelho A da CO, Lana FCF. Impact of the COVID-19 Pandemic on the Detection of Leprosy in Micro-Regions with a High Risk of Illness in Minas Gerais, Brazil. Infectious disease reports [Internet]. 2024;16(6):1098-107. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11675893/pdf/idr-16-00089.pdf
Type
1.
Hébélamou J, Grovogui FM, Manet H, Povogui L, Béavogui I, Kourouma K, et al. Trend and Factors Associated with Medical-Surgical Complications in Patients Discharged from Leprosy Multidrug Therapy at the Specialized Regional Hospital in Macenta, Guinea, from 2012 to 2021. Tropical medicine and infectious disease [Internet]. 2024;9(12):1-9. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11679088/pdf/tropicalmed-09-00290.pdf
Type
1.
Akhverdyan N, Cantor Z, Hawkins K. An alternative multidrug regimen for multibacillary Hansen’s disease: a case report. Journal of medical case reports [Internet]. 2024;18(1):1-4. Available from: https://jmedicalcasereports.biomedcentral.com/counter/pdf/10.1186/s13256-024-04971-9.pdf
Type
1.
Elhoseny RM, Hashem OA, Eldahshan RM, AbdAlsamie HS, Elsaie ML. Slit skin smear versus anti-phenolic glycolipid-I serology in diagnosis of leprosy: a cross sectional study. Archives of dermatological research. 2024;317(1).